BRPI0409516A - composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico - Google Patents

composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico

Info

Publication number
BRPI0409516A
BRPI0409516A BRPI0409516-2A BRPI0409516A BRPI0409516A BR PI0409516 A BRPI0409516 A BR PI0409516A BR PI0409516 A BRPI0409516 A BR PI0409516A BR PI0409516 A BRPI0409516 A BR PI0409516A
Authority
BR
Brazil
Prior art keywords
composition
pharmaceutical active
enhancing penetration
pharmaceutical
penetration
Prior art date
Application number
BRPI0409516-2A
Other languages
English (en)
Inventor
Claire Mallard
Franck Pitre
Laurent Fredon
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI0409516A publication Critical patent/BRPI0409516A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

"COMPOSIçãO, USO DE UMA COMPOSIçãO E PROCESSO DE MELHORA DA PENETRAçãO DE UM ATIVO FARMACêUTICO". A presente invenção trata de uma composição em forma de spray que compreende um ativo farmacêutico, pelo menos um silicone volátil e uma fase oleosa não volátil em um meio fisiologicamente aceitável, de seu processo de preparação e de seu uso em cosmética e em dermatologia.
BRPI0409516-2A 2003-06-23 2004-06-18 composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico BRPI0409516A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0307551A FR2856301B1 (fr) 2003-06-23 2003-06-23 Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
PCT/EP2004/007203 WO2004112798A1 (fr) 2003-06-23 2004-06-18 Compositions sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase huileuse non volatile

Publications (1)

Publication Number Publication Date
BRPI0409516A true BRPI0409516A (pt) 2006-04-18

Family

ID=33484645

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409516-2A BRPI0409516A (pt) 2003-06-23 2004-06-18 composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico

Country Status (15)

Country Link
US (2) US20060147383A1 (pt)
EP (1) EP1641463B1 (pt)
KR (1) KR20060021326A (pt)
CN (1) CN1809363A (pt)
AR (1) AR044872A1 (pt)
AT (1) ATE424829T1 (pt)
AU (1) AU2004248926A1 (pt)
BR (1) BRPI0409516A (pt)
CA (1) CA2526642A1 (pt)
DE (1) DE602004019922D1 (pt)
ES (1) ES2322269T3 (pt)
FR (1) FR2856301B1 (pt)
MX (1) MXPA05013232A (pt)
RU (1) RU2006101698A (pt)
WO (1) WO2004112798A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337870B2 (en) 2009-12-15 2012-12-25 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
AU2005253733A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin D derivative in an oily phase
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
CA2567684A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
US20070036731A1 (en) * 2005-08-13 2007-02-15 Collegium Pharmaceutical, Inc. Topical Delivery with a Carrier Fluid
FR2893845B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
AR068409A1 (es) * 2007-09-14 2009-11-18 Drugtech Corp Composiciones farmaceuticas, transdermicas sin alcohol
AR068408A1 (es) * 2007-09-14 2009-11-18 Drugtech Corp Pulverizacion de hormonas transdermicas
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
PT2496263T (pt) 2009-11-03 2022-03-28 Lipidor Ab Composição que forma uma camada lipídica para administração sobre uma superfície de um organismo vivo
US20120213843A1 (en) * 2009-11-03 2012-08-23 Lipidor Ab Composition for promoting wound healing
GB0919650D0 (en) 2009-11-10 2009-12-23 Futura Medical Developments Ltd Pharmaceutical composition
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
BR112013023458B1 (pt) 2011-03-14 2020-04-07 Drug Delivery Solutions Ltd composição oftálmica, e, método para fabricar a composição oftálmica
ITMI20121205A1 (it) * 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
US20160081916A1 (en) * 2013-05-03 2016-03-24 Lipidor Ab Topical Composition and Carrier for Administration of Pharmaceutically or Cosmetically Active Ingredients
KR102320051B1 (ko) 2013-10-03 2021-10-29 다우 파마슈티컬 사이언시즈, 인코포레이티드 안정화된 에피나코나졸 조성물
CA3052643A1 (en) 2013-11-22 2015-05-28 Bausch Health Ireland Limited Anti-infective methods, compositions, and devices
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US10149828B2 (en) 2015-01-09 2018-12-11 Chase Pharmaceuticals Corporation Oxybutynin transdermal therapeutic system combination
AU2016323770A1 (en) 2015-09-16 2018-03-29 Dfb Soria, Llc Delivery of drug nanoparticles and methods of use thereof
US20180000836A1 (en) * 2016-07-01 2018-01-04 Yousif Kattoula Topical Treatment for Psoriasis
JP2020514359A (ja) 2017-03-15 2020-05-21 ディーエフビー ソリア リミテッド ライアビリティ カンパニー タキサンのナノ粒子を用いる皮膚悪性腫瘍処置のための局所療法
CN206810524U (zh) 2017-05-31 2017-12-29 北京小米移动软件有限公司 一种水微粒发生装置
CN108970823B (zh) 2017-05-31 2021-08-06 北京小米移动软件有限公司 一种水微粒发生装置
KR20200132963A (ko) 2018-03-16 2020-11-25 디에프비 소리아, 엘엘씨 탁산의 나노입자를 사용하는 자궁경부 상피내 신생물 (cin) 및 자궁경부 암의 치료를 위한 국소적 요법
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
WO2019224035A1 (en) 2018-05-24 2019-11-28 Almirall, S.A. Topical pharmaceutical compositions comprising a corticosteroid

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US136332A (en) 1873-02-25 Improvement in prepared lumber for joiners use
DE3225848A1 (de) * 1982-07-07 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Kortikoidhaltige zubereitung zur topischen applikation
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4889845A (en) * 1986-06-09 1989-12-26 American Cyanamid Company Vehicle for topical application of pharmaceuticals
FI872553L (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Medium foer laekemedel foer lokalt bruk.
JPH02145512A (ja) * 1988-11-26 1990-06-05 Shin Etsu Chem Co Ltd 被膜形成型外用剤
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
EP0966972B1 (en) * 1998-06-18 2003-09-24 Dow Corning France S.A. Topical composition containing silicon gum
US5993837A (en) * 1998-08-24 1999-11-30 Revlon Consumer Products Compositions for application to keratinous substrates and a method for strengthening such substrates
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
ES2388425T5 (es) 1999-04-23 2020-02-12 Leo Pharma As Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
US6512072B1 (en) * 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
DE10113058A1 (de) * 2001-03-15 2002-09-19 Basf Ag Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2-(4-Alkoxy-anilinomethylen)-malonsäure-dialkylester enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
AU2005253733A1 (en) 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin D derivative in an oily phase

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337870B2 (en) 2009-12-15 2012-12-25 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system

Also Published As

Publication number Publication date
DE602004019922D1 (de) 2009-04-23
FR2856301A1 (fr) 2004-12-24
ATE424829T1 (de) 2009-03-15
FR2856301B1 (fr) 2007-08-03
ES2322269T3 (es) 2009-06-18
AR044872A1 (es) 2005-10-05
AU2004248926A1 (en) 2004-12-29
CN1809363A (zh) 2006-07-26
WO2004112798A1 (fr) 2004-12-29
US20060147383A1 (en) 2006-07-06
RU2006101698A (ru) 2006-06-10
KR20060021326A (ko) 2006-03-07
EP1641463A1 (fr) 2006-04-05
CA2526642A1 (fr) 2004-12-29
MXPA05013232A (es) 2006-03-09
US20100216757A1 (en) 2010-08-26
EP1641463B1 (fr) 2009-03-11

Similar Documents

Publication Publication Date Title
BRPI0114927B8 (pt) composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição
BRPI0510842A (pt) composição e seu uso
AR044872A1 (es) Composicion pulverizable que comprende un activo farmaceutico al menos una silicona volatil y una fase aceitosa no volatil
AR046642A1 (es) Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
BR0207726A (pt) Sais farmacêuticos
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
CY1107672T1 (el) Φαρμακευτικες και/ή κοσμητικες συνθεσεις για τη θεραπεια εντοπισμενου αδιπικου ιστου και κυτταριτιδας
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
CY1107033T1 (el) Συνθεση στη μορφη σπρεϊ η οποια περιλαμβανει ενα συνδυασμο προπιονικης κλομπεταζολης και καλσιτριολης, μια αλκοολικη φαση και μια ελαιωδη φαση
BRPI0701684A (pt) composição cosmética ou farmacêutica, processo de tratamento cosmético, uso de um composto e composto
DE602004012440D1 (de) Sprühbare zusammensetzung zur verabreichung von vitamin d derivaten
SE9802208D0 (sv) Novel compounds
DE602007010945D1 (de) Zusammensetzung mit mindestens einem c-glycosid-derivat und mindestens einer hyaluronsäure sowie ihre kosmetische anwendung
BR0203109A (pt) Composição de cuidado com a pele que altera a cor sob secagem
AR045649A1 (es) Una crema para modelar el cabello
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
NO20091517L (no) Emulsjon
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
MXPA05005170A (es) Gel despigmentante alcoholico acuoso que contiene un derivado fenolico y un retinoide.
BRPI0511389A (pt) composição e seu uso
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient
SE9802209D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.